Company intelligence / Profile preview

Ab E Discovery

Waterloo, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

Ab E Discovery developed an egg antibody technology (Cosabody) to improve gut health in poultry, which was globally in-licensed by Elanco for late-stage development and commercialization for animal health, specifically targeting coccidiosis and anti-nutritional gut challenges in poultry[4][6].

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Antibody
Industry: Veterinary

Partnerships

Elanco (global in-licensing and commercialization partner)

Beyond the preview

Go deeper on Ab E Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ab E Discovery.

Explore the full profile